Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18207
Country/Region: Kenya
Year: 2016
Main Partner: Columbia University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $2,039,788 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $333,429
Care: TB/HIV (HVTB) $104,979
Care: Pediatric Care and Support (PDCS) $62,259
Testing: HIV Testing and Counseling (HVCT) $64,400
Sexual Prevention: Other Sexual Prevention (HVOP) $155,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $252,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $189,555
Treatment: Adult Treatment (HTXS) $784,777
Treatment: Pediatric Treatment (PDTX) $93,389
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 200
HTS_TST Age/sex: 1-9 2017 1,321
HTS_TST Age/sex: 10-14 Female 2017 182
HTS_TST Age/sex: 10-14 Male 2017 183
HTS_TST Age/sex: 15-19 Female 2017 1,257
HTS_TST Age/sex: 15-19 Male 2017 601
HTS_TST Age/sex: 20-24 Female 2017 10,075
HTS_TST Age/sex: 20-24 Male 2017 8,864
HTS_TST Age/sex: 25-49 Female 2017 20,924
HTS_TST Age/sex: 25-49 Male 2017 13,830
HTS_TST Age/sex: 50+ Female 2017 6,864
HTS_TST Age/sex: 50+ Male 2017 1,574
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,113
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 771
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 40,975
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,016
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 65,875
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,998
HTS_TST Service Delivery Point (Facility): Inpatient 2017 8,247
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,090
HTS_TST Service Delivery Point (Facility): Outpatient 2017 35,797
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,428
HTS_TST Service Delivery Point (Facility): PMTCT 2017 8,247
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 303
HTS_TST Service Delivery Point (Facility): VCT 2017 5,554
HTS_TST Service Delivery Point (Facility): VMMC 2017 3,209
HTS_TST Sum of Age/Sex disaggregates 2017 64,354
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,884
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 63,991
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 65,875
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 30
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 18
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 208
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 121
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 1,199
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 704
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 209
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 123
HTS_TST_POS Test Result by Age: Positive: <1 2017 14
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 142
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 91
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 76
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,646
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 964
PMTCT_ART Already on ART at beginning of current pregnancy 2017 649
PMTCT_ART New on ART 2017 228
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 7,958
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 835
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 109
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 19
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 46
PMTCT_EID Sum of Infant Age disaggregates 2017 944
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 71
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 374
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 2,397
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 5,116
PMTCT_STAT By: Known positives at entry 2017 501
PMTCT_STAT By: Number of new positives identified 2017 176
PMTCT_STAT Number of new ANC and L&D clients 2017 7,958
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 7,958
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 2
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 8
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 63
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 358
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 71
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 22
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 125
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 25
PMTCT_STAT Sum of Positives Status disaggregates 2017 677
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 71
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 374
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 2,397
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 4,116
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 193
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 14
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 223
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 441
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 441
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,671
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,671
TB_SCREENDX Screen Result: Screened Positive for TB 2017 4,079
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 12,712
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 6,136
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 761
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 785
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 20,394
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 50
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 462
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 58
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 541
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,111
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,111
TX_CURR Age/Sex: <1 2017 13
TX_CURR Age/Sex: <1-9 2017 1,061
TX_CURR Age/Sex: 10-14 Female 2017 223
TX_CURR Age/Sex: 10-14 Male 2017 249
TX_CURR Age/Sex: 15-19 Female 2017 1,161
TX_CURR Age/Sex: 15-19 Male 2017 479
TX_CURR Age/Sex: 20-24 Female 2017 1,040
TX_CURR Age/Sex: 20-24 Male 2017 283
TX_CURR Age/Sex: 25-49 Female 2017 8,779
TX_CURR Age/Sex: 25-49 Male 2017 4,017
TX_CURR Age/Sex: 50+ Female 2017 1,732
TX_CURR Age/Sex: 50+ Male 2017 1,357
TX_CURR Aggregated Age/Sex: <15 Female 2017 761
TX_CURR Aggregated Age/Sex: <15 Male 2017 785
TX_CURR Aggregated Age/Sex: 15+ Female 2017 12,712
TX_CURR Aggregated Age/Sex: 15+ Male 2017 6,136
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 20,394
TX_CURR Sum of age/sex disaggregates 2017 1,640
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,546
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 18,848
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 20,394
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 204
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 198
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,962
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,499
TX_NEW By Age/Sex: <1 2017 51
TX_NEW By Age/Sex: 1-9 2017 198
TX_NEW By Age/Sex: 10-14 Female 2017 84
TX_NEW By Age/Sex: 10-14 Male 2017 69
TX_NEW By Age/Sex: 15-19 Female 2017 212
TX_NEW By Age/Sex: 15-19 Male 2017 87
TX_NEW By Age/Sex: 20-24 Female 2017 496
TX_NEW By Age/Sex: 20-24 Male 2017 110
TX_NEW By Age/Sex: 25-49 Female 2017 1,869
TX_NEW By Age/Sex: 25-49 Male 2017 1,027
TX_NEW By Age/Sex: 50+ Female 2017 385
TX_NEW By Age/Sex: 50+ Male 2017 275
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,863
TX_NEW Sum of Age/Sex disaggregates 2017 4,614
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,863
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 18,358
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 18,358
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 686
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 708
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 11,441
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 5,523
TX_PVLS Numerator: Indication: Routine 2017 18,358
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 686
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 708
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 11,441
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 5,523
TX_PVLS_den Denominator: Indication: Routine 2017 18,367
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 179
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 76
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 62
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 191
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 79
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 446
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 99
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,682
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 925
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 347
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 247
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 184
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 178
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,666
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,350
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,378
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,863
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 198
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 84
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 69
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 212
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 87
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 496
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 110
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,869
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,027
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 385
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 275
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 204
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 198
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,962
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,499
VMMC_CIRC By Age: 10-14 2017 1,286
VMMC_CIRC By Age: 15-19 2017 240
VMMC_CIRC By Age: 20-24 2017 149
VMMC_CIRC By Age: 25-29 2017 108
VMMC_CIRC By Age: 30-49 2017 137
VMMC_CIRC By Age: 50+ 2017 6
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 1,926
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 1,926
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 1,926
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 1,681